Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holsboer

Showing results (31-40 of 1,092) with videos related to

Pageof 110
Sort By:
Dialogues in Clinical Neuroscience|April 16, 2014
Redesigning antidepressant drug discoveryFlorian Holsboer
Acta Psychiatrica Scandinavica|June 1, 1987
Dexamethasone suppression test in severe schizophrenic illness: effects of plasma dexamethasone and caffeine levelsE Holsboer-Trachsler, C Buol, K Wiedemann, et al.
Therapeutische Umschau. Revue Therapeutique|June 5, 2009
[Pharmacotherapy of depression in primary care--an update]Edith Holsboer-Trachsler
Der Internist|July 1, 1997
[Treatment of sleep disorders]E Holsboer-Trachsler
Therapeutische Umschau. Revue Therapeutique|October 1, 1993
[Sleep disorders and depression]E Holsboer-Trachsler
Praxis|February 24, 2001
[Phytotherapeutic drugs and sleep]E Holsboer-Trachsler
Bibliotheca Psychiatrica|January 1, 1994
[Monitoring the neurobiological and psychopathological course in therapy of depression. Trimipramine, sleep deprivation and light]E Holsboer-Trachsler
Praxis|April 11, 1995
[Sleep disorders and their treatment]E Holsboer-Trachsler
The Journal of Biological Chemistry|April 26, 1996
Nuclear orphan receptor as a repressor of glucocorticoid receptor transcriptional activityT Trapp, F Holsboer
Journal of Neuroendocrinology|February 13, 2009
Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depressionU Bardeleben, F Holsboer
Pageof 110

Showing results (31-40 of 1,092) with videos related to

Sort By:
Pageof 110
Dialogues in Clinical Neuroscience|April 16, 2014
Redesigning antidepressant drug discoveryFlorian Holsboer
Acta Psychiatrica Scandinavica|June 1, 1987
Dexamethasone suppression test in severe schizophrenic illness: effects of plasma dexamethasone and caffeine levelsE Holsboer-Trachsler, C Buol, K Wiedemann, et al.
Therapeutische Umschau. Revue Therapeutique|June 5, 2009
[Pharmacotherapy of depression in primary care--an update]Edith Holsboer-Trachsler
Der Internist|July 1, 1997
[Treatment of sleep disorders]E Holsboer-Trachsler
Therapeutische Umschau. Revue Therapeutique|October 1, 1993
[Sleep disorders and depression]E Holsboer-Trachsler
Praxis|February 24, 2001
[Phytotherapeutic drugs and sleep]E Holsboer-Trachsler
Bibliotheca Psychiatrica|January 1, 1994
[Monitoring the neurobiological and psychopathological course in therapy of depression. Trimipramine, sleep deprivation and light]E Holsboer-Trachsler
Praxis|April 11, 1995
[Sleep disorders and their treatment]E Holsboer-Trachsler
The Journal of Biological Chemistry|April 26, 1996
Nuclear orphan receptor as a repressor of glucocorticoid receptor transcriptional activityT Trapp, F Holsboer
Journal of Neuroendocrinology|February 13, 2009
Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depressionU Bardeleben, F Holsboer
Pageof 110